Genethera Stock Price on November 28, 2024
| GTHR Stock | USD 0.0001 0.00 0.00% |
If you're considering investing in GeneThera Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of GeneThera stands at 0.0001, as last reported on the 28th of November, with the highest price reaching 0.0001 and the lowest price hitting 0.0001 during the day. We have found three technical indicators for GeneThera, which you can use to evaluate the volatility of the firm.
GeneThera Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
GeneThera |
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| GTHR |
Based on monthly moving average GeneThera is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of GeneThera by adding GeneThera to a well-diversified portfolio.
GeneThera Valuation on November 28, 2024
It is possible to determine the worth of GeneThera on a given historical date. On November 28, 2024 GeneThera was worth 1.0E-4 at the beginning of the trading date compared to the closed value of 1.0E-4. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of GeneThera pink sheet. Still, in general, we apply an absolute valuation method to find GeneThera's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of GeneThera where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against GeneThera's related companies.
| Open | High | Low | Close | Volume | |
| 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
11/28/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 0.00 |
| Backtest GeneThera | | | GeneThera History | | | GeneThera Valuation | Previous |
GeneThera Trading Date Momentum on November 28, 2024
| On November 28 2024 GeneThera was traded for 0.0001 at the closing time. The top price for the day was 0.0001 and the lowest listed price was 0.0001 . There was no trading activity during the period 0.0. Lack of trading volume on November 28, 2024 did not cause price change. The overall trading delta against the current closing price is 0.00% . |
GeneThera Fundamentals Correlations and Trends
By evaluating GeneThera's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among GeneThera's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. GeneThera financial account trend analysis is a perfect complement when working with valuation or volatility modules.About GeneThera Pink Sheet history
GeneThera investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for GeneThera is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in GeneThera will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing GeneThera stock prices may prove useful in developing a viable investing in GeneThera
GeneThera, Inc., a biotechnology company, develops molecular assays and therapeutics for the detection and treatment of zoonotic diseases. The companys Molecular RoboticAI Platform and Therapeutic strategy is designed to prevent the spread of disease from animals and allow to better control of zoonotic infectious agents. Genethera operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 2 people.
GeneThera Pink Sheet Technical Analysis
GeneThera technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Price Boundaries
GeneThera Period Price Range
Low | November 28, 2024
| High |
0.00 | 0.00 |
GeneThera cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
GeneThera November 28, 2024 Market Strength
Market strength indicators help investors to evaluate how GeneThera pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading GeneThera shares will generate the highest return on investment. By undertsting and applying GeneThera pink sheet market strength indicators, traders can identify GeneThera entry and exit signals to maximize returns
Additional Tools for GeneThera Pink Sheet Analysis
When running GeneThera's price analysis, check to measure GeneThera's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneThera is operating at the current time. Most of GeneThera's value examination focuses on studying past and present price action to predict the probability of GeneThera's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneThera's price. Additionally, you may evaluate how the addition of GeneThera to your portfolios can decrease your overall portfolio volatility.